BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 33032902)

  • 21. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
    Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal Relationship Between Lichen Sclerosus, Differentiated Vulvar Intra-epithelial Neoplasia and Non HPV-related Vulvar Squamous Cell Carcinoma.
    Pouwer AW; VAN DEN Einden LCG; VAN DER Linden M; Hehir-Kwa JY; Yu J; Hendriks KM; Kamping EJ; Eijkelenboom A; Massuger LFAG; Bulten J; VAN Tilborg AAG; DE Hullu JA; Kuiper RP
    Cancer Genomics Proteomics; 2020; 17(2):151-160. PubMed ID: 32108037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Landscape of Vulvar Squamous Cell Carcinoma.
    Carreras-Dieguez N; Guerrero J; Rodrigo-Calvo MT; Ribera-Cortada I; Trias I; Jares P; López Del Campo R; Saco A; Munmany M; Marimon L; Ferrando M; Vega N; Del Pino M; Torné A; Ordi J; Rakislova N
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva.
    Parra-Herran C; Nucci MR; Singh N; Rakislova N; Howitt BE; Hoang L; Gilks CB; Bosse T; Watkins JC
    Mod Pathol; 2022 Oct; 35(10):1317-1326. PubMed ID: 35437330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Molecular Sequencing of Recurrent and Multifocal Non-HPV-associated Squamous Cell Carcinoma of the Vulva.
    Pors J; Tessier-Cloutier B; Thompson E; Almadani N; Ho J; Gilks B; Huntsman D; Hoang L
    Int J Gynecol Pathol; 2021 Jul; 40(4):391-399. PubMed ID: 33323855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas.
    Pinto AP; Lin MC; Mutter GL; Sun D; Villa LL; Crum CP
    Am J Pathol; 1999 Apr; 154(4):1009-15. PubMed ID: 10233839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas.
    Ramberg I; Vieira FG; Toft PB; von Buchwald C; Funding M; Nielsen FC; Heegaard S
    Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):11. PubMed ID: 34779821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva.
    Han MR; Shin S; Park HC; Kim MS; Lee SH; Jung SH; Song SY; Lee SH; Chung YJ
    Exp Mol Med; 2018 Feb; 50(2):e442. PubMed ID: 29422544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.
    Swarts DRA; Voorham QJM; van Splunter AP; Wilting SM; Sie D; Pronk D; van Beurden M; Heideman DAM; Snijders PJF; Meijer CJLM; Steenbergen RDM; Bleeker MCG
    Cancer Med; 2018 Sep; 7(9):4542-4553. PubMed ID: 30030907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putative precancerous lesions of vulvar squamous cell carcinoma.
    Jenkins TM; Mills AM
    Semin Diagn Pathol; 2021 Jan; 38(1):27-36. PubMed ID: 32948383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
    Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W
    Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.
    Allo G; Yap ML; Cuartero J; Milosevic M; Ferguson S; Mackay H; Kamel-Reid S; Weinreb I; Ghazarian D; Pintilie M; Clarke BA
    Int J Gynecol Pathol; 2020 Jul; 39(4):391-399. PubMed ID: 31274700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome.
    Gordinier ME; Schau GF; Pollock SB; Shields LBE; Talwalkar S
    Gynecol Oncol; 2024 Jan; 180():111-117. PubMed ID: 38086165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic characterization of vulvar squamous cell carcinoma.
    Prieske K; Alawi M; Oliveira-Ferrer L; Jaeger A; Eylmann K; Burandt E; Schmalfeldt B; Joosse SA; Woelber L
    Gynecol Oncol; 2020 Sep; 158(3):547-554. PubMed ID: 32591094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma.
    Kortekaas KE; Solleveld-Westerink N; Tessier-Cloutier B; Rutten TA; Poelgeest MIE; Gilks CB; Hoang LN; Bosse T
    Histopathology; 2020 Jul; 77(1):92-99. PubMed ID: 32236967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.
    Lérias S; Esteves S; Silva F; Cunha M; Cochicho D; Martins L; Félix A
    Mod Pathol; 2020 May; 33(5):893-904. PubMed ID: 31844270
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Lozar T; Keske A; Dube Mandishora RS; Yu Q; Bailey A; Xu J; Tommasino M; McGregor SM; Lambert PF; Gheit T; Fitzpatrick MB
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.